Michael Ryskin
Stock Analyst at Bank of America Securities
(4.32)
# 1,356
Out of 4,683 analysts
708
Total ratings
59.7%
Success rate
5.6%
Average return
Main Sectors:
Stocks Rated by Michael Ryskin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IDXX IDEXX Laboratories | Maintained: Hold | $660 → $665 | $550.01 | +20.91% | 33 | Aug 14, 2026 | |
| ELAN Elanco Animal Health | Maintained: Buy | $32 → $34 | $25.09 | +35.51% | 36 | Aug 12, 2026 | |
| ALMR Alamar Biosciences | Reiterated: Hold | $27 → $31 | $33.02 | -6.12% | 2 | Aug 10, 2026 | |
| TXG 10x Genomics | Maintained: Hold | n/a | $64.72 | - | 28 | Aug 7, 2026 | |
| SDGR Schrödinger | Maintained: Buy | n/a | $19.99 | - | 23 | Aug 6, 2026 | |
| CAI Caris Life Sciences | Maintained: Buy | n/a | $28.01 | - | 9 | Aug 6, 2026 | |
| BRKR Bruker | Maintained: Buy | n/a | $56.85 | - | 26 | Aug 5, 2026 | |
| ILMN Illumina | Maintained: Sell | $140 | $224.99 | -37.78% | 48 | Aug 5, 2026 | |
| STVN Stevanato Group | Maintained: Buy | n/a | $22.70 | - | 14 | Aug 5, 2026 | |
| WAT Waters | Maintained: Hold | $400 → $415 | $414.44 | +0.14% | 21 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $230 | $215.97 | +6.50% | 41 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $4 → $3.2 | $3.19 | +0.31% | 11 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $64 → $52 | $68.73 | -24.34% | 18 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $1,402.25 | - | 13 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $164.92 | - | 19 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | n/a | $159.61 | - | 25 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $150 → $160 | $168.91 | -5.28% | 22 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $320 → $360 | $337.68 | +6.61% | 13 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | n/a | $18.27 | - | 13 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $77.29 | - | 44 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $245 → $280 | $259.42 | +7.93% | 18 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | n/a | $35.93 | - | 15 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $245 → $265 | $244.51 | +8.38% | 17 | Jul 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $410 | $348.48 | +17.65% | 17 | Jul 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $630 → $650 | $628.15 | +3.48% | 30 | Jul 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $2.4 | $1.89 | +26.98% | 10 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $11 → $16 | $16.79 | -4.71% | 14 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $297.64 | - | 19 | Jun 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $145 → $155 | $154.77 | +0.15% | 24 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $124.84 | - | 17 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $56 → $49 | $43.65 | +12.26% | 16 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $13 → $11 | $14.42 | -23.72% | 21 | Feb 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 → $8 | $9.00 | n/a | 13 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 → $17 | $8.14 | n/a | 12 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $10 | $7.54 | n/a | 1 | Jul 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $10 → $2.4 | $9.63 | n/a | 3 | Apr 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $31 → $10 | $3.56 | n/a | 2 | Apr 18, 2022 |
IDEXX Laboratories
Aug 14, 2026
Maintained: Hold
Price Target: $660 → $665
Current: $550.01
Upside: +20.91%
Elanco Animal Health
Aug 12, 2026
Maintained: Buy
Price Target: $32 → $34
Current: $25.09
Upside: +35.51%
Alamar Biosciences
Aug 10, 2026
Reiterated: Hold
Price Target: $27 → $31
Current: $33.02
Upside: -6.12%
10x Genomics
Aug 7, 2026
Maintained: Hold
Price Target: n/a
Current: $64.72
Upside: -
Schrödinger
Aug 6, 2026
Maintained: Buy
Price Target: n/a
Current: $19.99
Upside: -
Caris Life Sciences
Aug 6, 2026
Maintained: Buy
Price Target: n/a
Current: $28.01
Upside: -
Bruker
Aug 5, 2026
Maintained: Buy
Price Target: n/a
Current: $56.85
Upside: -
Illumina
Aug 5, 2026
Maintained: Sell
Price Target: $140
Current: $224.99
Upside: -37.78%
Stevanato Group
Aug 5, 2026
Maintained: Buy
Price Target: n/a
Current: $22.70
Upside: -
Waters
Aug 4, 2026
Maintained: Hold
Price Target: $400 → $415
Current: $414.44
Upside: +0.14%
Aug 3, 2026
Maintained: Buy
Price Target: $230
Current: $215.97
Upside: +6.50%
Aug 3, 2026
Reiterated: Sell
Price Target: $4 → $3.2
Current: $3.19
Upside: +0.31%
Aug 3, 2026
Reiterated: Hold
Price Target: $64 → $52
Current: $68.73
Upside: -24.34%
Jul 31, 2026
Maintained: Buy
Price Target: n/a
Current: $1,402.25
Upside: -
Jul 31, 2026
Maintained: Buy
Price Target: n/a
Current: $164.92
Upside: -
Jul 30, 2026
Maintained: Sell
Price Target: n/a
Current: $159.61
Upside: -
Jul 30, 2026
Reiterated: Sell
Price Target: $150 → $160
Current: $168.91
Upside: -5.28%
Jul 30, 2026
Reiterated: Buy
Price Target: $320 → $360
Current: $337.68
Upside: +6.61%
Jul 30, 2026
Maintained: Sell
Price Target: n/a
Current: $18.27
Upside: -
Jul 28, 2026
Maintained: Hold
Price Target: n/a
Current: $77.29
Upside: -
Jul 28, 2026
Reiterated: Buy
Price Target: $245 → $280
Current: $259.42
Upside: +7.93%
Jul 28, 2026
Maintained: Sell
Price Target: n/a
Current: $35.93
Upside: -
Jul 24, 2026
Reiterated: Buy
Price Target: $245 → $265
Current: $244.51
Upside: +8.38%
Jul 24, 2026
Reiterated: Buy
Price Target: $410
Current: $348.48
Upside: +17.65%
Jul 23, 2026
Maintained: Buy
Price Target: $630 → $650
Current: $628.15
Upside: +3.48%
Jul 15, 2026
Maintained: Sell
Price Target: $2.4
Current: $1.89
Upside: +26.98%
Jul 13, 2026
Maintained: Hold
Price Target: $11 → $16
Current: $16.79
Upside: -4.71%
Jun 5, 2026
Maintained: Buy
Price Target: n/a
Current: $297.64
Upside: -
Jun 2, 2026
Reiterated: Buy
Price Target: $145 → $155
Current: $154.77
Upside: +0.15%
May 14, 2026
Maintained: Hold
Price Target: n/a
Current: $124.84
Upside: -
May 13, 2026
Maintained: Buy
Price Target: $56 → $49
Current: $43.65
Upside: +12.26%
Feb 11, 2026
Reiterated: Hold
Price Target: $13 → $11
Current: $14.42
Upside: -23.72%
Mar 3, 2025
Maintained: Buy
Price Target: $9 → $8
Current: $9.00
Upside: n/a
Feb 27, 2025
Reiterated: Buy
Price Target: $15 → $17
Current: $8.14
Upside: n/a
Jul 18, 2024
Maintained: Sell
Price Target: $10
Current: $7.54
Upside: n/a
Apr 24, 2023
Maintained: Sell
Price Target: $10 → $2.4
Current: $9.63
Upside: n/a
Apr 18, 2022
Downgraded: Hold
Price Target: $31 → $10
Current: $3.56
Upside: n/a